Skip to main content Back to Top
Advertisement

11/7/2016

Sodium Bicarbonate Injection

Products Affected - Description

    • Sodium Bicarbonate injection, Amphastar, 8.4%, 50 mL syringe, 10 count, NDC 00548-3352-01

Reason for the Shortage

    • Amphastar has sodium bicarbonate available.
    • Fresenius Kabi is not currently manufacturing sodium bicarbonate 4.2% 5 mL vials.
    • Hospira has sodium bicarbonate available.
    • Hospira is the sole supplier of the 4.2% 10 mL syringes used in pediatric patients.

Available Products

    • Sodium Bicarbonate injection, Amphastar, 8.4%, 50 mL syringe, 10 count, NDC 76329-3352-01
    • Sodium Bicarbonate injection, Pfizer, 4.2%, 10 mL LifeShield syringe, 10 count, NDC 00409-5534-34
    • Sodium Bicarbonate injection, Pfizer, 7.5%, 50 mL LifeShield syringe, 10 count, NDC 00409-4916-34
    • Sodium Bicarbonate injection, Pfizer, 8.4%, 10 mL syringe, 10 count, NDC 00409-4900-34
    • Sodium Bicarbonate injection, Pfizer, 8.4%, 50 mL LifeShield syringe, 10 count, NDC 00409-6637-34
    • Sodium Bicarbonate injection, Pfizer, 8.4%, 50 mL vial, 25 count, NDC 00409-6625-02

Estimated Resupply Dates

    • All marketed presentations are available.

Updated

Updated November 7, 2016 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 5, 2015 by Jane Chandramouli, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins